Claims for Patent: 4,657,761

Summary for Patent: 4,657,761

Title:	Polyvalent non-specific immuno-stimulating vaccine and method
Abstract:	A non-specific therapeutic polyvalent vaccine for subcutaneous injection containing a minimum combination of a PPD (tuberculin vaccine), a rabies vaccine, and snake venom vaccine and preferably including at least a DTP vaccine in addition and optimally a mumps antigen vaccine and Dermatophytin vaccine in controlled levels, all such constituent vaccines being commercially available. The vaccine provides a broad-based stimulation or potentiation of the immuno-defense system of the patient and is useful for the symptomatic relief and/or mitigation of diseases of viral origin, such as Herpes Zoster, labialis and genitalis, various neuralgias, mumps, measles, viral hepatitis, psoriasis and severe acne, or of autoimmune origin, such as multiple sclerosis and arthritis.
Inventor(s):	Pinto; Cesar M. (Guatemala C, GT)
Assignee:
Application Number:	06/741,344
Patent Claims:	1. A non-specific therapeutic polyvalent vaccine for stimulating the immuno-defense system of a patient suffering from neuralgia, herpes complex, measles, mumps, psoriasis, arthritis, multiple sclerosis, viral hepatitis, and acne and providing symptomatic relief therefor, which consists essentially of a therapeutic amount of a mixture of a purified protein derivative (PDD) vaccine, a rabies vaccine, and snake vemom vaccine. 2. A polyvalent vaccine of claim 1 containing in addition a combined diphtheria, tetanus, pertusis (DTP) vaccine as adjuvant. 3. A polyvalent vaccine of claim 2 containing in addition a mumps virus vaccine and Dermatophytin vaccine. 4. The polyvalent vaccine of claim 3 wherein said constituent vaccines are present in an individual dosage in the following ranges of proportions 5. A method for stimulating the immune defense system of a patient suffering from neuralgia, herpes complex, measles, mumps, psoriasis, arthritis, multiple sclerosis, viral hepatitis, and acne which comprises administering to the patient for introduction into the system thereof a disease mitigating amount of the polyvalent vaccine of claim 1. 6. A method for stimulating the immune defense system of a patient suffering from neuralgia, herpes complex, measles, mumps, psoriasis, arthritis, multiple sclerosis, viral hepatitis, and acne which comprises administering to the patient for introduction into the humoral system thereof a disease mitigating amount of the polyvalent viral vaccine of claim 2. 7. A method for stimulating the immune defense system of a patient suffering from neuralgia, herpes complex, measles, mumps, psoriasis, arthritis, multiple sclerosis, viral hepatitis, and acne which comprises administering to the patient for introduction into the humoral system thereof a disease mitigating amount of the polyvalent viral vaccine of claim 3. 8. The method of claim 1 wherein said vaccine is administered subcutaneously.

Details for Patent 4,657,761

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Bavarian Nordic A/s	RABAVERT	rabies vaccine	For Injection	103334	10/20/1997		2040-01-28
Sanofi Pasteur Sa	IMOVAX RABIES	rabies vaccine	For Injection	103931	02/04/2000		2040-01-28